Protagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021

Press/Media

Period7 Jun 2021 → 8 Jun 2021

Media coverage

2

Media coverage

  • Title-Protagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date8/06/21
    PersonsRonald Hoffman
  • TitleProtagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date7/06/21
    PersonsRonald Hoffman